Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists

被引:5
作者
Pizzi, Domenica Antonia [1 ]
Leslie, Colin Philip [1 ]
Mazzali, Angelica [1 ]
Seri, Catia [1 ]
Biagetti, Matteo [1 ]
Bentley, Jonathan [1 ]
Genski, Thorsten [1 ]
Di Fabio, Romano [1 ]
Contini, Stefania [1 ]
Sabbatini, Fabio Maria [1 ]
Zonzini, Laura [1 ]
Caberlotto, Laura [1 ]
机构
[1] GlaxoSmithKline Inc, Neurosci Ctr Excellence Drug Discovery, Med Res Ctr, I-37135 Verona, Italy
关键词
NPY Y5; Benzimidazoles; NEUROPEPTIDE-Y; RECEPTOR; MECHANISMS; OBESITY;
D O I
10.1016/j.bmcl.2010.09.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of benzimidazole NPY Y5 receptor antagonists was prepared exploiting a privileged spirocarbamate moiety. The structure-activity relationship of this series and efforts to achieve a profile suitable for further development and an appropriate pharmacokinetic profile in rat are described. Optimisation led to the identification of the brain penetrant, orally bioavailable Y5 antagonist 9b which significantly inhibited the food intake induced by a Y5 selective agonist with a minimal effective dose of 30 mg/kg po. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7120 / 7123
页数:4
相关论文
共 50 条
[41]   Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians [J].
CP Jenkinson ;
K Cray ;
K Walder ;
H Herzog ;
R Hanson ;
E Ravussin .
International Journal of Obesity, 2000, 24 :580-584
[42]   The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis [J].
Yokosuka, M ;
Dube, MG ;
Kalra, PS ;
Kalra, SP .
PEPTIDES, 2001, 22 (03) :507-514
[43]   Parallel synthesis and pharmacological screening of nonpeptide ligands of the neuropeptide Y receptor subtype Y5 [J].
Henlin, JM ;
Boutin, JA ;
Duchêne-Roger, F ;
Nicolas, JP ;
Desmet-Beaufort, C ;
Levens, N ;
Fauchère, JL .
JOURNAL OF PEPTIDE RESEARCH, 2001, 57 (05) :419-427
[44]   Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy [J].
Gao, Zhongli ;
Hurst, William J. ;
Hall, Daniel ;
Hartung, Ryan ;
Reynolds, William ;
Kang, Jiesheng ;
Nagorny, Raisa ;
Hendrix, James A. ;
George, Pascal G. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (03) :429-438
[45]   Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists [J].
Weiss, Stefan ;
Keller, Max ;
Bernhardt, Guenther ;
Buschauer, Armin ;
Koenig, Burkhard .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) :9858-9866
[46]   Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists [J].
Mittapalli, Gopi Kumar ;
Vellucci, Danielle ;
Yang, Jun ;
Toussaint, Marion ;
Brothers, Shaun P. ;
Wahlestedt, Claes ;
Roberts, Edward .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) :3916-3920
[47]   Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists [J].
Takeda, Kunitoshi ;
Terauchi, Taro ;
Shin, Kogyoku ;
Ino, Mitsuhiro ;
Shibata, Hisashi ;
Yonaga, Masahiro .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) :4756-4761
[48]   The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes [J].
Wyss, P ;
Stricker-Krongrad, A ;
Brunner, L ;
Miller, J ;
Crossthwaite, A ;
Whitebread, S ;
Criscione, L .
REGULATORY PEPTIDES, 1998, 75-6 :363-371
[49]   An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice [J].
Fukasaka, Yumiko ;
Nambu, Hirohide ;
Tanioka, Hideki ;
Obata, Atsushi ;
Tonomura, Misato ;
Okuno, Takayuki ;
Yukioka, Hideo .
NEUROPEPTIDES, 2018, 70 :55-63
[50]   5-(2′-Pyridyl)-2-aminothiazoles: Alkyl amino sulfonamides and sulfamides as potent NPY5 antagonists [J].
Packiarajan, Mathivanan ;
Coate, Heather ;
Desai, Mahesh ;
Jimenez, Hermogenes N. ;
Reinhard, Emily J. ;
Jubian, Vrej J. ;
Marzabadi, Mohammad R. ;
Chandrasena, Gamini ;
Wolinski, Toni C. ;
Walker, Mary W. ;
Andersen, Kim .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) :6500-6504